Press release
Eisenmenger Syndrome Treatment Market Will Exhibit an Impressive Expansion by 2024-2031
July 2021- The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the US Food and Drug Administration (FDA) has approved UPTRAVI (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension in adult patients with WHO functional class (FC) II-III, who are temporarily unable to take oral therapy. UPTRAVI IV is a therapeutic option that will allow patients to avoid short-term treatment interruptions and stay on UPTRAVI therapy, as uninterrupted treatment is considered key for individuals with PAH.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/eisenmenger-syndrome-treatment-market
April 2021- The US FDA has granted a second approval to treprostinil (Tyvaso) inhalation solution, for the patines. Tyvaso DPI is the only therapy approved by the FDA for PH-ILD, when the blood pressure in the lungs is high due to a disease that causes lung scarring. Moreover, the convenience and portability of Tyvaso DPI make it an important new option for patients with WHO Group 1 PAH and with WHO Group 3 PH-ILD, with the potential for improving the quality of life for this patient population.
Global Eisenmenger Syndrome Treatment Market- Segmentation
By Drug Type
• Antiarrhythmic Agents
• Blood Thinning Agents
• Endothelin Receptor Antagonist
• Others
By Diagnosis
• Blood tests
• Electrocardiogram (ECG)
• Chest X-ray
• Echocardiogram
• Computerized tomography (CT) scan
• Magnetic resonance imaging (MRI)
• Cardiac catheterization
By Distribution Channel
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
A full report of Eisenmenger Syndrome Treatment Market is available at: https://www.omrglobal.com/industry-reports/eisenmenger-syndrome-treatment-market
Eisenmenger Syndrome Treatment Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Eli Lilly and Co.
• Gilead Sciences, Inc.
• GlaxoSmithKline
• Hikma Pharmaceuticals PLC
• Lupin Ltd.
• Merck & Co., Inc.
• Natco Pharma Ltd.
• Sun Pharma
• Viatris Inc
• Zydus Pharmaceuticals (USA) Inc.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eisenmenger Syndrome Treatment Market Will Exhibit an Impressive Expansion by 2024-2031 here
News-ID: 3467622 • Views: …
More Releases from Orion Market Research
Feed Carotenoids Market is Size, Trends, Latest Insights, Analysis and Forecast …
Feed carotenoids market is anticipated to grow at a considerable CAGR of 3.6% during the forecast period. The shift from animal ownership to animal parenting has been a very crucial and defining trend in the pet food market, more so in developed countries. According to the National Pet Owners Survey performed by the American Pet Products Association (APPA), more than 85 million households in the US had one or more…
Carotenoids Market Is Expected to Exhibit Significant Growth Over 2031 Allied Bi …
Carotenoids Market is expected to grow at a CAGR of 3.0% during the forecast period. The possesses huge potential as carotenoids are an essential antioxidant that plays a crucial role in human health. These are potent antioxidants that can help prevent some forms of cancer and heart disease and supports to enhance the immune response to infections. Most common carotenoids include astaxanthin, beta carotene, lutein, zeaxanthin, and lycopene. Certain carotenoids…
Beta Carotene Market Increasing Demand, Growth Analysis and Future Outlook by 20 …
Global beta carotene market is anticipated to grow at a significant CAGR of 11.3% during the forecast period (2024-2031). The increasing consumer awareness regarding the health benefits associated with beta carotene consumption is a key factor driving the global market. Beta carotene, a natural pigment found in various fruits and vegetables, is a precursor of vitamin A and acts as a potent antioxidant in the human body. Its role…
Veterinary Infectious Diseases Therapeutics Market Analysis and Forecast 2024-20 …
The global veterinary infectious diseases therapeutics market is expected to grow at a significant CAGR during the forecast period. Microorganisms, such as bacteria and viruses, are tiny living entities that can be found everywhere. Only a few of the hundreds of microbe species invading, multiplying, and causing sickness in animals and humans. Most germs dwell on the skin, in the mouth, upper airways, and intestines without causing disease, however, depending…
More Releases for Eisenmenger
Nutraceutical Product Market Size, Share, Statistics, Trends, Competitive analys …
The most recent study offered by Acumen Research and Consulting focuses Nutraceutical Product Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Nutraceutical Product Market trends in order to assess its current and future potential. Our Nutraceutical Product Market analysis also provides market participants and new entrants with a comprehensive…
Custom Procedure Packs Market value is set to grow by USD 15.1 Billion from 2022 …
The most recent study offered by Acumen Research and Consulting focuses Custom Procedure Packs Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Custom Procedure Packs Market trends in order to assess its current and future potential. Our Custom Procedure Packs Market analysis also provides market participants and new entrants…
Antidiabetics Market Market: Global Opportunity Analysis, market share, SWOT and …
The most recent study offered by Acumen Research and Consulting focuses Antidiabetics Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Antidiabetics Market trends in order to assess its current and future potential. Our Antidiabetics Market analysis also provides market participants and new entrants with a comprehensive view of the…
Eisenmenger Syndrome Treatment Market Share, Industry Dynamics, Global Trends an …
The exclusive research report on 'Eisenmenger Syndrome Treatment Market' now available with 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Eisenmenger Syndrome Treatment Market.
The research report incorporates a…
Eisenmenger Syndrome Treatment Market Size will Grow Profitably in the Near Futu …
Global Eisenmenger Syndrome Treatment Market: Introduction
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger syndrome is caused due to a birth defect. The disease is characterized by high blood pressure and abnormal blood flow through the heart. The specific symptoms of Eisenmenger syndrome vary greatly from person to person. The most notable symptom is called cyanosis, which is the bluish discoloration of the…
Eisenmenger Syndrome Treatment Market Analysis with Forecast By Leading Key Play …
Eisenmenger Syndrome develops due to high blood pressure in the lungs, which is known as pulmonary hypertension. Pulmonary hypertension occurs due to certain congenital heart defects that cause the blood to flow from left side of the heart to right side abnormally (left-to-right shunt). The congenital heart defects causing this condition include Patent ductus arteriosus (PDA), atrial septal defect (ASD), Ventricular septal defect (VSD), and Atrioventricular canal defect (AV canal).…
